Open AccessA Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017
Author(s) -
Kim JungHyun,
Alderton Alex,
Crook Jeremy M.,
Benvenisty Nissim,
Brandsten Catharina,
Firpo Meri,
Harrison Peter W.,
Kawamata Shin,
Kawase Eihachiro,
Kurtz Andreas,
Loring Jeanne F.,
Ludwig Tenneille,
Man Jennifer,
Mountford Joanne C.,
Turner Marc L.,
Oh Steve,
da Veiga Pereira Lygia,
Pranke Patricia,
Sheldon Michael,
Steeg Rachel,
Sullivan Stephen,
Yaffe Michael,
Zhou Qi,
Stacey Glyn N.
Publication year - 2019
Publication title -
stem cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.159
H-Index - 229
eISSN - 1549-4918
pISSN - 1066-5099
DOI - 10.1002/stem.3003
Subject(s) - stem cell , induced pluripotent stem cell , biology , alliance , harmonization , library science , embryonic stem cell , political science , microbiology and biotechnology , computer science , genetics , law , physics , acoustics , gene
This report summarizes the recent activity of the International Stem Cell Banking Initiative held at Harvard Stem Cell Institute, Boston, MA, USA, on June 18, 2017. In this meeting, we aimed to find consensus on ongoing issues of quality control (QC), safety, and efficacy of human pluripotent stem cell banks and their derivative cell therapy products for the global harmonization. In particular, assays for the QC testing such as pluripotency assays test and general QC testing criteria were intensively discussed. Moreover, the recent activities of global stem cell banking centers and the regulatory bodies were briefly summarized to provide an overview on global developments and issues. Stem Cells 2019;37:1130–1135